Cocaine and Amphetamines Study Notes

Chapter 4: Cocaine

Historical Origins of Coca Leaf

  • Source of Coca:
    • Coca leaf comes from small leaves of the coca shrub (scientific name: Erythroxylon).
    • Use traces back to the Inca civilization in the 13th century; people chewed coca leaves.
    • Coca was considered a divine gift from the sun god Inti to the Incas.
  • Growing Regions:
    • Coca is primarily grown in the rainforests along the Peru and Bolivian Andes.
  • Indigenous Use:
    • Andean peoples chewed coca leaves for various reasons:
    • Energy enhancement.
    • Relief from altitude sickness.
    • Religious ceremonies.
    • Social customs.

Key Distinction

  • Coca Leaf vs. Modern Cocaine:
    • The coca leaf contains only small amounts of cocaine.
    • Modern cocaine is a highly concentrated, purified extract of the coca plant.

Cocaine during the 18th Century

  • Introduction to Europe:
    • Cocaine was brought to Europe from Spanish colonies, although its potency was diminished.
  • Alfred Niemann (1859):
    • German chemist who discovered cocaine's anesthetic effect on the tongue.
    • He identified its mechanism to block sodium channels that prevent sensory receptors on the tongue from firing.

Angelo Mariani and Commercial Cocaine

  • Pioneering Marketing:
    • Angelo Mariani was a French chemist who began marketing cocaine.
    • Created "Mariani's Coca Wine," combining coca extract with Bordeaux wine.
  • Endorsements:
    • The product received endorsements from notable figures such as:
    • Pope Leo XIII
    • Thomas Edison
    • President of the USA
    • European royalty.
  • Marketing Strategy:
    • Positioned cocaine as a health tonic rather than a recreational substance.

Dr. John Stith Pemberton (1885)

  • Coca-Containing Beverage:
    • Pemberton, an Atlanta pharmacist, created a beverage called "Pemberton's French Wine Coca."
    • He later removed the alcohol and added carbonated water, using coca syrup.
    • Marketed as a brain tonic that enhances productivity and alleviates nervous ailments.
  • Reformulation and Coca-Cola:
    • The drink was reformulated without cocaine due to temperance movements, becoming "Coca-Cola."
    • Coca was banned in medicines by 1906 and 1908.

William Halsted

  • Research and Dependency:
    • He studied cocaine's effect on anesthetizing nerves and limbs, leading to his dependency on the drug.

Sigmund Freud's Involvement (1884)

  • Early Advocacy:
    • Sigmund Freud is recognized for being an early advocate of cocaine use, trying it in 1884.
  • Treatment Beliefs:
    • Freud believed cocaine could be a treatment for:
    • Morphine addiction.
    • Depression.
    • Digestive disorders.
  • Historical Irony:
    • Although Freud later recognized the dangers and addiction potential of cocaine, his initial advocacy contributed to its popularity in European medical circles.

19th Century Cocaine Use

  • Medicinal Applications:
    • Throughout the 19th century, cocaine was prescribed by physicians as a topical medication.
    • It found applications in eye surgery and dental work.

Cocaine in Popular Literature (Late 19th Century)

  • Cocaine in Fiction:
    • Sherlock Holmes:
    • The character injects a 7% cocaine solution when bored, ascribed effects include enhanced energy and deduction prowess.
    • Dr. Jekyll and Mr. Hyde:
    • Robert Louis Stevenson reportedly wrote the story during a period of cocaine treatment for tuberculosis; themes of transformation echo cocaine's euphoric qualities.

How Cocaine Works in the Brain

  • Mechanism of Action:
    • Cocaine blocks the reuptake of neurotransmitters:
    • Dopamine
    • Serotonin
    • Norepinephrine
    • This action leads to increased dopamine activity in the nucleus accumbens, promoting feelings of euphoria and reinforcement.
    • Strong involvement of the dopamine transporter in addiction processes.
  • Research Methodology:
    • Conditioned Place Preference (CPP) in rodents is used to measure the reward from cocaine exposure.
    • Removal of dopamine and serotonin transporters leads to a lack of preference for cocaine exposure among test subjects.

Acute Effects of Cocaine

  • Immediate Effects:
    • Produces a significant burst of energy.
    • Smoking or injecting cocaine results in an intense rush lasting approximately 5-10 minutes; snorting can produce effects lasting about 15-30 minutes.
    • As the effects wear off, users commonly experience:
    • Irritability.
    • Depression.
    • Strong cravings.
    • Initial doses may increase sexual arousal, but prolonged use often diminishes sexual desire and performance.

Physiological Effects

  • Activation of the Sympathetic Nervous System:
    • Increases heart rate, respiration, and blood pressure.
    • Causes blood vessel constriction, elevating the risk of cardiovascular issues.
  • Behavioral Impacts:
    • Users develop overconfidence and impaired motor skills, leading to higher likelihood of risky behaviors, like reckless driving.

Cardiovascular Effects of Cocaine

  • **Physiological Response: **
    • Stimulates the sympathetic nervous system, resulting in:
    • Increased heart rate and contraction efficiency.
    • Vasoconstriction, leading to higher blood pressure.
  • High Dose Complications:
    • In high doses, cocaine can block sodium channels in heart cells, potentially leading to arrhythmias.
    • Chronic use raises the risks of stroke and heart failure.

Chronic Effects of Cocaine

  • Long-Term Use Consequences:
    • Can cause:
    • Persistent irritability
    • Depression
    • Paranoia
    • Cocaine psychosis.
    • Chronic nasal issues may arise from snorting, leading to bleeding and potential septum damage.
    • Reduced dopamine receptors in the Ventral Tegmental Area, which lessens the ability to experience pleasure over time.
    • Users often develop tolerance to euphoric effects.
    • Sensitization can lead to an increased risk of seizures and potential overdose, even at lower doses.

Treatment Approaches for Cocaine Dependence

  • Cocaine Anonymous:
    • Provides peer support akin to Alcoholics Anonymous.
  • Cognitive Behavioral Therapy:
    • Focuses on changing thought patterns, managing mood, and developing refusal skills.
  • Medication Research:
    • Vigabatrin is known to boost GABA levels and may help reduce cravings for cocaine.
    • Other prospective medications include:
    • Baclofen
    • Tiagabine
    • Topiramate
    • Disulfiram
    • Modafinil
  • Challenges:
    • Relapse rates are high due to strong conditioned cues, necessitating long-term treatment and preventive strategies.

Medical Uses of Cocaine

  • Topical Application:
    • Cocaine can be applied on skin to block action potential transmission from sensory receptors.
    • It serves as a legitimate anesthetic in nasal, tear duct, and throat surgeries.
  • Disadvantages:
    • Cocaine absorbs quickly into the bloodstream and constricts blood vessels.
  • Alternatives:
    • Local anesthetics such as lidocaine are considered superior.

Legal Consequences

The Opium and Other Drugs Act (Canada, 1911)

  • Key Legislation:
    • Marked the first major Canadian laws controlling psychoactive substances, criminalizing possession and trafficking of:
    • Opium
    • Cocaine
    • Other narcotics.
  • Significance:
    • Laid the foundation for early drug prohibition frameworks in Canada, influenced by international treaties and U.S. laws.

Chapter 4: Amphetamines (ATSs)

Definition and Historical Context

  • ATS Definition:
    • Amphetamine-Type Stimulants (ATS) refer to a class including substances such as:
    • Amphetamine
    • Dextroamphetamine
    • Methamphetamine.
  • Historical Background:
    • The initial discovery dates to the late 19th century (1887) by Romanian chemist Lazăr Edeleanu, gaining widespread use by the mid-20th century.

Medical Applications Today

  1. Narcolepsy:
    • Promotes wakefulness and decreases sudden sleep attacks.
  2. ADHD (Attention-Deficit Hyperactivity Disorder):
    • Improves focus and impulse control.
    • Common formulations include:
      • Adderall (mixed amphetamine salts)
      • Ritalin (methylphenidate—different classification but with similar effects).

The Different Forms of Amphetamines

  • Amphetamine Structure:
    • Composed of carbon (C), hydrogen (H), and nitrogen (N) atoms.
    • Exists in two forms:
    • Right-handed (dextroamphetamine or d-amphetamine) – more potent.
    • Left-handed (levoamphetamine or l-amphetamine).
  • Dextroamphetamine:
    • Known as d-amphetamine, it is stronger than its left-handed counterpart (l-amphetamine).
    • Marketed under the brand name Dexedrine.
    • A key component of Adderall.
  • Methamphetamine:
    • A chemically modified variant of d-amphetamine, where a methyl group (CH₃) replaces a hydrogen atom.
    • This modification improves the drug's ability to penetrate the blood-brain barrier.
    • Abused widely under names like meth, crystal meth, or speed.

The History of Amphetamines

  • Historical Origin:
    • Amphetamines trace back to the Chinese herb ma huang, utilized for respiratory ailments.
    • Ephedrine, the active ingredient, was isolated in 1887.
  • Development and Use:
    • First marketed as "Benzedrine" in 1932, functioning as a CNS stimulant and bronchial dilator; usage expanded during WWII to maintain soldier alertness.
  • Advantages over Cocaine:
    • Amphetamines can be taken orally and provide longer-lasting effects than cocaine.
  • Post-War Adaptation:
    • Post-WWII, amphetamines surged in popularity among students and truck drivers seeking alertness; this subsequently increased recreational use due to euphoric effects.
  • Regulation and Abuse:
    • Classed as Schedule G drugs in 1961, leading to regulatory controls; illegal amphetamine production and use persisted.
  • Decline and Resurgence:
    • During the 1960s, usage peaked but declined with cocaine's resurgence, then re-emerged in the mid-1990s.
    • In Canada, amphetamines are presently classified as Schedule I drugs.

How Amphetamines Work in the Brain

  • Neurotransmitter Activity:
    • Amphetamines closely resemble dopamine and norepinephrine, boosting their activity in the brain.
  • Dopamine Transporter Mechanism:
    • They block the dopamine transporter, hindering dopamine reuptake into presynaptic terminals.
    • At elevated concentrations, they reverse transporter function, pushing dopamine into the synapse.
  • Norepinephrine and Serotonin Transporters:
    • They also bind to norepinephrine and serotonin transporters, increasing neurotransmitter levels in the synaptic cleft.
    • Affinity for these transporters varies among different types of amphetamines.

Specific Effects of Amphetamines

  • Different Types:
    • MDMA exhibits strong affinity for the serotonin transporter, producing mild hallucinogenic effects.
    • Methamphetamine mainly affects the dopamine transporter, with the potential to damage dopamine terminals, manifesting symptoms similar to schizophrenia.
  • Dopamine and Positive Reinforcement:
    • Dopamine is crucial in brain regions tied to positive reinforcement, such as the nucleus accumbens; the euphoric effects and cravings for amphetamines stem from altered dopamine activity.

Acute and Chronic Effects of Amphetamines

Acute Effects
  • Amphetamine Effects:
    • Both d-amphetamine and methamphetamine mirror cocaine effects but endure significantly longer (typically 8 to 24 hours).
  • Physiological Changes:
    • Increased sympathetic nervous system activation, including rapid breathing, heightened heart rate, hyperthermia, and elevated blood pressure.
  • Psychological Effects:
    • Users typically experience euphoria, feelings of invincibility, decreased appetite, and enhanced alertness and energy.
  • Adverse Effects:
    • Dangerous consequences may include convulsions, chest pains, and heightened stroke risk.
Chronic Effects
  • Methamphetamine Abuse:
    • Severe psychological effects can develop, such as formication hallucinations, where users feel insects sensation under their skin, prompting self-harm behaviors.
  • Compulsive Behaviors:
    • Users may engage in repetitive actions and experience compulsive jaw movements and teeth grinding, leading to dental damage.
  • Amphetamine Psychosis:
    • Chronic use may induce paranoia, bizarre delusions, hallucinations, and mood swings, resembling paranoid schizophrenia, attributed to overstimulation of dopamine-releasing neurons.
  • "Tweaking":
    • Up to 50% of methamphetamine abusers encounter "tweaking," characterized by irritability, paranoia, and potential violence, especially following prolonged sleep deprivation.
  • Long-Term Health Risks:
    • Methamphetamine use correlates with brain chemistry changes similar to those seen in Parkinson's disease, implying a risk of developing Parkinson-like symptoms later in life.
    • However, abstaining for a year or more can partially reverse changes induced by chronic use.

Present-Day Trends in Amphetamine Abuse

Methamphetamine Abuse Trends

  • Resurgence:
    • Methamphetamine abuse re-emerged in the 1990s following the decline of crack and powder cocaine use.
    • It became a major stimulant of abuse in Canada, particularly among working-class individuals.
  • Street Names and Administration Methods:
    • Various street names include:
    • "meth"
    • "speed"
    • "Tina"
    • "crank"
    • "crystal meth."
    • Administration methods vary, including:
    • Snorting
    • Injecting
    • Smoking.
  • Effects Duration:
    • Injection and inhalation yield effects in under 2 minutes lasting 3-7 hours; intranasal use takes about 5-10 minutes for effects lasting 4-10 hours, while oral administration spans 20-60 minutes for effects lasting 5-12 hours.
  • Historical Context and Trafficking:
    • Early 1990s distribution was predominantly controlled by organized crime in southern California and Mexico, followed by small-scale "homegrown" labs manufacturing in rural U.S. areas complicating enforcement efforts.
  • Environmental and Social Impact:
    • Production causes toxic waste, contaminating soil and water areas.
    • Children face dangers from toxic fumes, fires, and neglect due to meth-dependent parents.

Regulatory Measures

  • Sales Limitations:
    • Limited sales of pseudoephedrine in 1997, triggering trafficking from Canada.
    • Canada’s Precursor Control Regulations initiated in 2003, regulating chemicals needed for meth production.
  • Methamphetamine as a Club Drug:
    • Particularly in its smokable form known as "ice" or "crystal meth," the high purity enhances dependence potential, correlating with high-risk behaviors among certain demographics.

Stimulant Medication and Cognitive Enhancement

Ritalin and Adderall Misuse

  • Warning of Abuse:
    • Ciba-Geigy issued a warning in 1996 regarding Ritalin abuse among youths for stimulant effects.
  • Adderall Misuse Trends:
    • Younger Canadians (ages 15-24) are more likely to misuse stimulants than those ages 25 and older, attributed to easier access in educational settings.

Ethical Concerns

  • Cognitive Enhancers:
    • The application of cognitive enhancers raises ethical questions, with anticipated debates surrounding their usage and potential for misuse increasing in corpus.

Methamphetamine Abuse Treatment

Treatment Considerations

  • Usage Patterns:
    • Both methamphetamine and cocaine elevate dopamine levels but yield dissimilar consumption patterns.
    • Methamphetamine is typically consumed throughout the day in regular intervals, contrasting with cocaine usage, often occurring in binge-like phases mostly at night.
  • Effects Duration:
    • Methamphetamine’s effects last longer, potentially leading to more frequent cocaine use required to sustain perceived effects.
  • Cognitive Impairments:
    • Individuals abusing methamphetamine showcase significantly greater perceptual speed impairments and information manipulation deficits in tasks demanding both compared to cocaine users.
  • Withdrawal and Treatment:
    • Withdrawal symptoms mirror cocaine withdrawal, encompassing a spectrum of immediate challenges and potential long-term consequences.

Chapter 5: Opioids

Opioid Overview

  • Definition and Nature:
    • Opioids are a class of psychoactive drugs recognized for their pain-relieving properties.
    • They have a high potential for addiction, producing a dream-like state and inducing sleep at higher doses.

Categories of Opioids

  • Natural Compounds:
    • Extracted directly from opium; examples include:
    • Morphine
    • Codeine
    • Thebaine.
    • All opioid derivatives originate from these natural bases.
  • Morphine Derivatives:
    • Created through chemical structure modulation of morphine; examples include:
    • Heroin
    • Hydromorphone (Dilaudid).
  • Codeine and Thebaine Derivatives:
    • Formed through semi-synthetic modifications; examples include:
    • Oxycodone (e.g., OxyIR, Supreudol)
    • Controlled-release form (e.g., OxyContin, OxyNEO).
  • Synthetic Opioids:
    • Fully manufactured in laboratories; examples include:
    • Methadone
    • Meperidine (Demerol)
    • Tramadol (Ultram)
    • Buprenorphine (Butrans, Suboxone).

Historical Context and Significance

  • Misapplication of Narcotic Term:
    • The term "narcotic" was historically applied to opioids due to their sleep-inducing qualities but misleadingly associated it with other psychoactive substances like cocaine and amphetamines, which do not induce sleep.

Opium Harvesting and Origin

  • Opium Source:
    • Derived from the opium poppy (Papaver somniferum), harvested for over 3000 years.
    • Commonly cultivated in hot climate regions using cheap labor, primarily in countries like Myanmar, Afghanistan, and Mexico.
  • Harvesting Methodology:
    • Involves making incisions in the poppy capsule to extract the milky juice, which hardens into opium.

Historical Use of Opium

  • Ancient References:
    • Evidence of opium use dates back to the third century B.C.E., noted during the Late Bronze Age.
    • Ancient Egyptians documented its medicinal uses in the Ebers Papyrus.
  • Medicinal Applications:
    • By the second century C.E., physician Claudius Galen endorsed opium for diverse ailments, showcasing early instances of over-prescription despite no ancient records of recreational use or dependency.
  • Introduction to Western Europe:
    • Cannabis entered European society in the 11th and 12th centuries through the Crusades, when it gained popularity as a therapeutic drug amid the rise of modern medicine.

Opium Drinks and Recreational Use

Historical Popularity

  • Laudanum Production:
    • Created by Paracelsus in 1520, laudanum combines opium with wine and spices as a medicinal drink.
    • Thomas Sydenham contributed to opium-based drinks' popularity, becoming a common remedy in Europe and North America for over two centuries.
  • Recreational Status:
    • Opium drinks established opium as a significant recreational substance in both Europe and North America.

The Opium War

  • Medicinal Origins:
    • Opium's initial application in China for medicinal purposes (e.g., pain relief and diarrhea) was maintained for over 800 years.
    • The emergence of opium smoking in the 18th century presented a growing issue.
  • British Trade Influence:
    • The British introduced Indian-grown opium to China post-conquest of Bengal Province in 1773, which fueled trade despite government resistance.
  • Social and Public Health Issues:
    • Opium dependence escalated particularly in southern Chinese port cities such as Canton, prompting official edicts focused on curbing consumption; these efforts failed.
  • War Triggered by Edicts:
    • The Opium War (1839) ignited after the destruction of confiscated opium by Chinese officials, leading to military conflict and a British victory that led to treaties expanding foreign influence and legalizing opium trade from the British.

Opium in Britain

Consumption Trends

  • Common Use Amongst Populations:
    • By the mid-1800s, opium was frequently used in Britain (notably as laudanum), having social acceptance compared to the stigma surrounding opium smoking.
  • Society and Costs:
    • It became cheaper than gin or beer; chronic users were socially comparable to alcoholics.
  • Parents and Children:
    • Opium was often given to infants to treat issues like teething pain, particularly among working-class families.

Opium's Cultural and Literary Impact

Influence on Writers

  • Literary Usage:
    • Society's acceptance of opium led some authors, as seen in Thomas DeQuincey's "Confessions of an English Opium Eater," to portray the drug as a source of creative inspiration.
    • Influences extended to notable figures such as Elizabeth Barrett Browning and Samuel Taylor Coleridge.

Canada and Opium Use

Canadian Context in the 1800s

  • Recreational Drug Status:
    • Opium served as a common recreational substance alongside alcohol and nicotine, particularly laudanum for diverse medicinal applications.
  • Marketing to Alcohol Dependency:
    • Marketing targeted alcohol-dependent individuals incorporating opium, thus potentially fostering cycles of dependency.
  • Racial Prejudices:
    • Anti-Chinese sentiments contributed to backlash against smoking, associating it with moral degradation of youth through opium dens.
  • Legislation and Control Measures:
    • The San Francisco ordinance prohibited opium smoking in 1875 due to moral concerns; later federal laws focused on production and use restrictions.

Morphine and Heroin's Introduction

Morphine Isolation

  • Discovery and Isolation:
    • Morphine was isolated by Friedrich Wilhelm Adam Sertürner in 1803, containing around 10% of opium's weight and being 10 times more potent than raw opium.

Introduction of Heroin

  • Development by Bayer Company in 1898:
    • Heroin was introduced as a painkiller initially believed to be non-addictive and is typically three times stronger than morphine.
  • Potency Characteristics:
    • Heroin's increased potency arises from its two acetyl groups’ configuration, enhancing its fat solubility, allowing for rapid access to the brain with effects mirroring morphine.
  • Risks of Misunderstanding:
    • Heroin's addiction potential was not recognized until 1910, highlighting significant oversights in its medical administration.

Opioids in Society

Dependence Levels

  • Opioid Dependency:
    • By 1900, the number of opioid dependents in the U.S. was estimated at 250,000 to over 2 million, signifying a major shift in societal perception and management of addiction.
  • Comparative Stats:
    • In 2011, around 281,000 Americans aged 12 and older reported having engaged with heroin, reflecting the intensive historical trajectory of opioid abuse.
  • Calls for Regulation:
    • The emergence of widespread opioid use and associations with criminality propelled requests for governmental measures to alleviate social disruptions.

Opioid Legislation and Societal Impact

Canada's Opium Act of 1908

  • Prohibitory Measures:
    • This Act made the importation, manufacturing, and sale of opiates for non-medicinal uses illegal, signifying Canada as the first western nation to outlaw opiates.
  • Penalties Enforced:
    • Breaking the Act could result in sentences ranging from three years imprisonment and/or fines equivalent to between $50 to $1000 (modern equivalence of $1000 to $21,000).

Emergence of Heroin on the Black Market

  • Shift to Illegal Trade:
    • Owing to the Opium Act, heroin transformed into a sought-after black-market drug, often refined from raw opium.
  • Formation of Illicit Markets:
    • The legislation engendered the establishment of black markets for such substances.

The Opium and Drug Act of 1911

  • Expanded Legislation:
    • Beyond heroin, the law included cocaine and morphine within its ambit and imposed stricter penalties for violations.

Effects on Mind and Body

  • Acute Effects of Heroin:
    • Immediate effects of heroin include sensations of warmth in the abdomen, intense euphoria, and tranquil drowsiness (termed "on the nod").
    • Effects last for about three to four hours; withdrawal symptoms commence roughly four hours after use.
  • Influential Factors:
    • Effects can differ based on numerous factors:
    • Quantity consumed
    • Purity levels
    • Route of administration
    • Time since last dose
    • Individual tolerance
      effects.
  • Physiological Reactions:
    • Heroin can lead to nausea/vomiting through activation of medullary reflex centers and stimulate histamine release, engendering itchiness and redness conditions.

Respiratory and Cardiovascular Consequences

  • Respiratory System Impact:
    • Depresses respiratory centers in the medulla, reducing breathing sensitivity and, at excessive doses, risking respiratory cessation.
  • Cardiovascular Effects:
    • Impacts blood pressure, likely results in hypotension while diminishing immune capacity.
  • Gastrointestinal Effects:
    • Reduces gastrointestinal transit speed, causing constipation and defecation difficulties.

The Effects of Opioids on the Brain

  • Psychoactive Interaction:
    • Opioids influence synaptic transmission by modulating specifically targeted neurotransmitter transporters and receptors.
    • They activate specific opioid receptors first noted in the 1970s, predominantly influencing endogenous opioids such as endorphins which modulate pain and emotional responses.
  • Discovery Impact:
    • Opioid-sensitive receptors contribute to elucidating analgesic and euphoric properties stemming from substance use.

Naloxone Usage

  • Role as an Antagonist:
    • Naloxone works as a competitive antagonist at opioid receptors, notably mu receptors, widely applied in emergency situations to reverse overdoses (e.g., alleviate respiratory depression and blood pressure declines).
  • Endogenous Opioid Peptides Role:
    • Endorphins and other natural compounds act similarly to opioid drugs through their interaction with central nervous system receptors.
  • Therapeutic Applicability:
    • Naloxone reverses opioid effects efficiently; Naltrexone addresses heroin abuse and alcohol dependency, especially in extended-release formats (e.g., Vivitrol).
  • Combined Therapies:
    • Naltrexone paired with extended-release morphine (Embeda) provides pain relief while minimizing addiction risks.

Receptors Involved in Opioids

  • Types of Endogenous Opioids:
    • Include endorphins, enkephalins, and dynorphins; pivotal for pain management, emotional control, and immune system interaction.
  • Opiate Receptor Classes:
    • Five types: μ (mu), δ (delta), κ (kappa), nociception (NOR), and ζ (zeta); distributed throughout the CNS (central nervous system) and spinal cord regions.
  • Receptor Concentration:
    • These are primarily present in the rostreal ventromedial medulla, locus coeruleus, and periaqueductal grey matter, which influence pain transmission.

Mechanism of Action for Opiate Receptors

  • Operative Mechanism:
    • Opiate receptors function as GPCRs (G-protein coupled receptors) and impact secondary messaging to reduce neurotransmitter release or induce neuron hyperpolarization.
  • Addiction Pathways:
    • Heroin and related substances predominantly engage µ receptors, decreasing GABA release that subsequently enhances dopamine release in the nucleus accumbens, reinforcing reward and euphoria feelings.

Patterns of Heroin Abuse

Routes of Administration
  • Common Methods:
    • Intravenous injection (mainlining/shooting) is the prime mode; alternatives involve smoking, snorting, or subcutaneous injections (skin-popping).
  • Regional Popular Variants:
    • Smoking remains common in Middle Eastern regions compared to Canadian practices.
  • New User Trends:
    • New users often snort or inject subcutaneously, while experienced users avoid needles, opting for less invasive subcutaneous methods.
  • Oral Consumption Ineffectiveness:
    • Oral ingestion is mostly ineffective due to low absorption rates.

Tolerance and Withdrawal Symptoms

Chronic Use and Tolerance
  • Opioid Dependence Development:
    • Chronic use ambers varied tolerance levels; gastrointestinal effects like constipation exhibit minimal tolerance relative to recommendations for diminished euphoric or analgesic potency.
  • Dose-Dependent Tolerance:
    • Tolerance severity correlates with the dosage consumed; higher doses induce more pronounced tolerance.
  • Withdrawal Dynamics:
    • Symptoms typically present 4-6 hours after the last dosage, peak at 36-72 hours, resolving around 5-10 days (some long-term effects may persist up to 6 months).

Psychological and Social Elements

  • Reinforcement in Relapse:
    • Factors arising from social contexts influencing prior experiences often reinforce drug-taking behavior.
  • Comprehensive Treatment Approaches:
    • Effective treatment strategies should comprehensively tackle physical, psychological, and social dimensions associated with heroin abuse.

The Lethality of Heroin Abuse

  • Relative Toxicity:
    • Heroin is deemed to have low systemic toxicity over prolonged periods without detectable organ damage.
  • Administration Risks:
    • Particularly harmful practices like vapor inhalation of heated heroin greatly elevate mucocele neurologically consequential risks.
  • Dangerous Practices:
    • Abusing heroin is recognized for inherent dangers, particularly concerning practices that enhance severity of associated disorders.

Heroin and Societal Perception

Complexity in Addiction Narratives
  • Ultimate Addiction Viewpoint:
    • Heroin addiction is often perceived as the ultimate form of addiction; while many abusers engage in illegal activities, a significant proportion arises from noncriminal associations.
  • Controlled Heroin Use (Chipping):
    • A term encapsulates users who manage consumption levels; a study in 1984 indicated some could regulate intake without developing compulsive dependence for extended durations.
  • Long-term Outcomes and Risks:
    • Many long-term heroin users face high mortality rates, commonly attributed to overdoses or toxic exposure from heroin adulteration; similar to gambling, dependence results in dangerous repercussions.

Treatment for Heroin Abuse

Heroin Detoxification Strategies

  • Detox Processes:
    • Detoxification, or withdrawal management, may be medically overseen through gradual tapering of heroin levels.
  • Transitional Medications:
    • Alternatives such as meperidine (Demerol) or methadone substitute during detox processes.
  • Gradual Reduction Protocols:
    • Transitional drug doses systematically decrease over approximately two weeks to facilitate withdrawal management.

Methadone Maintenance Treatment

  • Challenges in Detox:
    • Initial detox can elicit significant cravings; naloxone can alleviate withdrawal symptoms during detox stages.
  • Roots of Methadone Treatment:
    • Initiated in the 1960s as heroin substitute strategies, methadone alleviates cravings while allowing a stable quality of life adoption.
  • Benefits of Methadone:
    • Methadone is legal and cost-effective; it aims to curb criminality associated with heroin dependency.
    • Its effects persist for around 24 hours without producing euphoria.
  • Program Structure and Results:
    • Clients receive daily methadone doses, often mixed with juice; doses increase rooted in drug-free urinary analysis.
  • Program Outcomes:
    • Mixed results; reductions in intravenous drug use observed and incrementally improved employment rates noted, though encompassing only a small fraction of the heroin-dependent community.

Alternative Maintenance Programs

  • LAAM (Levo-alpha-acetylmethadol):
    • Acts longer than methadone, requiring tri-weekly administration, though it is not approved by Health Canada.
  • Buprenorphine:
    • Approved by Health Canada; allows prescription beyond specialized treatments, enhancing accessibility.
  • Buprenorphine and Naloxone Joint Administration (Suboxone):
    • Reduces abuse potentials, inducing withdrawal if improperly injected; fosters long-term opioid receptor blockage, mitigating euphoric effects.
  • Advantages of Buprenorphine:
    • Cost-effective for clinics; permits less supervised environments, reducing stigma surrounding treatment access.

Medical Uses of Opioid Drugs

Context and Application

  • Opioids in Pain Management:
    • Effective primarily for managing pain; morphine remains a traditionally preferred opioid.
    • Fentanyl patches increasingly used for chronic pain management due to fewer side effects compared to standard opioids.
  • Other Opioid Derivatives:
    • Hydrocodone (Hycodan), methadone (Metadol), and meperidine (Demerol) administered across multiple dosing formats.
    • Fentanyl available in oral formulations and varying dosages based on need.
    • Tramadol (Ultram) specifically comes in a 50 mg oral extended-release format.
  • Miscellaneous Considerations:
    • Codeine varies between 30 mg to 60 mg, with sub-variant exposures noted.
    • Hydromorphone (Dilaudid) accessible in varied forms and strengths (1 mg to 8 mg).
    • Oxycodone exists as controlled-release forms (e.g., OxyContin, OxyNEO), dosing ranging 2.5 mg to 80 mg.

Beneficial Effects of Opioids

  • Medicinal Benefits:
    • Primarily utilized for its analgesic capabilities; effective against acute diarrhea and for cough suppression applications.
  • Pain Management Choices:
    • Morphine typically favored, while fentanyl patches offer advantages regarding chronic pain treatment, exerting reduced side effects compared to conventional opioid formats.
  • Diarrhea Treatment:
    • Opioids slow intestinal movements beneficially; Loperamide (Imodium) exemplifies efficacy without central depressant properties.
  • Cough Suppression:
    • Codeine prescribed primarily for cough suppression, with alternative options like Dextromethorphan coming under scrutiny for increasing misuse.

Prescription Pain Medication Misuse and Abuse

Drug Benefits vs. Side Effects

  • Utilitarian Impact:
    • While opioids serve pivotal pain relief functions, they are coupled with severe side effects, including respiratory depression, which poses risks to predisposed patients.
  • Contrasting Digestive Impacts:
    • These medications impair hydrochloric acid secretion and suppress intestinal activity, prompting gastrointestinal spasms.
  • Sleep and Usage Patterns:
    • High doses elicit somnolence, recommended primarily when pain disrupts sleep cycles.
  • Prevalence of Misuse:
    • Opioid misuse remains widespread, with prevalent medications such as OxyContin and Percocet being frequently abused nonmedically.

OxyContin Abuse Overview

  • Introduction and Misuse Trajectory:
    • Launched in 1995, OxyContin was initially characterized as safe but saw abuse rates spiral when crushed, prompting effects comparable to heroin.
  • Consequences:
    • Resulted in notable addiction and withdrawal reactions parallel to those of heroin, incurring an estimated $504 million economic cost in Canada in 2011.

Regulatory Changes Surrounding OxyContin

Market Withdrawal

  • Health Canada Actions:
    • Withdraw OxyContin from marketplaces in 2012; subsequent introduction of OxyNEO designed to deter tampering.
  • Limitations of OxyNEO:
    • The formulation deters crushing and alteration, though addiction potentials remain high, prompting strict regulatory measures in regions like Ontario and British Columbia.

Fentanyl and Its Rise

Introduction and Potency

  • Synthetic Development:
    • Synthesized by Dr. Paul Janssen in 1960, fentanyl operates as an agonist of mu opioid receptors, vastly more potent than morphine (up to 100x stronger).
  • Usage in Europe:
    • Initially employed for pain management strategies.
  • Advantages:
    • Features shorter action durations, avoids histamine release, and maintains stability in cardiovascular activity, affording expedited recoveries during anesthesia.

Production Costs and Routes of Administration

  • Cost Efficiency:
    • As a synthetic compound, manufacturing costs are reduced compared to morphine, which necessitates opium extraction processes.
  • Administration Modalities:
    • Typically injected during surgical procedures, also available via transdermal patches and rapid onset delivery systems that are prone to misuse.

Overdose Crisis Association

  • Rising Overdoses:
    • The spike in fentanyl-related overdoses and fatalities is prominently noted in Canada, highlighting an escalating fentanyl crisis.
  • Carfentanil Context:
    • An extremely potent opioid, exceeding fentanyl strength (100x) and morphine significantly (10,000x); utilized principally for tranquilizing large animals.
  • Classification:
    • Designated as a Schedule I drug with no accepted medicinal use and marked by a high abuse potential; entered illicit markets around 2016.

Assessing Opioid Pain Medications

Composition and Risks

  • Percocet Description:
    • Comprising oxycodone and acetaminophen; misuse at elevated doses can result in toxicity owing to exceeding recommendations.

Medication Diversion Trends

  • Prescription Diversion:
    • A considerable proportion of prescription pain relievers are diverted, frequently accessed via friends or relatives with prescriptions.

Effects On Mind and Body

Opioid Overarching Effects

  • Psycho-social Impacts:
    • Core impacts include euphoria, pain relief, digestive suppression (notably constipation), and respiratory depression prevalent in opioids such as heroin.
  • Interacting Receptor Dynamics:
    • A principal feature in opioid activity is the interaction with opiate receptors within the brain, which normally operate via endogenous release facilitated by endorphins.

Tolerance and Withdrawal Dynamics

  • Impact of Chronic Use:
    • Long-term usage leads to heightened tolerance development, necessitating larger dosages for relief; withdrawal symptoms often run counter to heroin effects, presenting a formidable recovery challenge.

Chapter 6: LSD & Other Hallucinogens

Albert Hofmann's Accidental Discovery

  • Initial Encounter:
    • Chemist Albert Hofmann encountered the first LSD experience in 1943 while with Sandoz Pharmaceuticals.

Experimentation Outcomes

  • Presumed Ineffectiveness:
    • Hofmann originally believed the 0.25 mg dose didn't yield effects but soon learned otherwise.
    • This quantity was approximately five times the average dose level, inducing intense sensory distortions and hallucinations.

LSD Effects Observed

  • Key Experiences:
    • Hallucinogenic effects included:
    • Visual distortions.
    • Altered body sense.
    • Blending sensory perceptions (e.g. hearing colors).
  • Affected Experience Spectrum:
    • Hallucinogenic responses can range from frightening to pleasurable, illustrated through Hofmann's experiential contrasts.

Cultural and Historical Context

  • Ancient and Contemporary Origins:
    • Hallucinogenic substances have both ancient and modern roots, with known psychoactive material spanning various plant species.
    • An estimated 6000 plant types worldwide have psychoactive properties.

Terminology and Attitudes Towards Hallucinogens

  • Attitudinal Variance:
    • Terminology reflective of user attitudes:
    • Positive: Psychedelic (mind-expanding), Entheogenic (connection with the divine).
    • Negative: Psychotomimetic (psychosis-like), Psychodysleptic (mind-disrupting), Psycholytic (mind-dissolving).
    • Neutral: Hallucinogenic, referring to hallucination-producing capacities.

Differentiating Hallucinations from Illusions

  • Definitions:
    • Hallucinations:
    • Perceptions of non-existent entities.
    • Hallucinogens:
    • Typically alter existing perceptual environments, with suggested terms like "illusionogenic" for enhanced clarity.

Classifying Hallucinogens

Classification Metrics

  • Chemical Similarity to Neurotransmitters:
    • Hallucinogens are classified based on similarity to neurotransmitters affecting:
    • Serotonin
    • Norepinephrine
    • Acetylcholine
    • Glutamate
    • GABA receptors.
  • Acetylcholine-Related Hallucinogens:
    • Includes substances like:
    • Atropine
    • Scopolamine
    • Hyoscyamine (antagonists of muscarinic acetylcholine).

Indolamine Hallucinogens

  • Chemically Identified:
    • Chemically analogous to serotonin, including:
    • LSD
    • Psilocybin
    • Morning glory seeds
    • DMT
    • Harmine.
  • Mechanism Engagement:
    • They act primarily as 5-HT2 agonists impacting serotonin pathways.

Phenethylamine Hallucinogens

  • Characteristics:
    • Linked with norepinephrine dynamics, examples comprising:
    • Mescaline
    • DOM
    • MDMA
    • MDA.
  • Mechanistic Actions:
    • Primarily function via 5-HT2 agonism.

Miscellaneous Hallucinogens

  • Diverse Categories Include:
    • Muscimol, Ibotenic acid, PCP, Ketamine, Salvia divinorum, each exhibiting varying mechanistic actions such as:
    • GABAA agonism
    • NMDA antagonism
    • Kappa opioid agonism.

Lysergic Acid Diethylamide (LSD)

LSD Origins and Ergotism

  • Synthesis and Background:
    • LSD is a synthetic hallucinogen derived from ergot fungi found on moldy grains.
  • Historical Connection to Ergotism:
    • Two forms of ergotism are known, one inducing gangrene/loss of limbs, and the other inducing hallucinations.

Mechanisms in Brain and Body

Serotonin-2A Receptors
  • Hallucinogenic Mechanisms:
    • The primary effects of LSD result from stimulating serotonin-2A (5-HT2A) receptors.
  • Diverse Receptor Subtypes:
    • There are 15 subtypes of serotonin receptors, categorized into seven groups (5-HT1−7), with most linked to G-proteins affecting second messenger systems, with exceptions in the 5-HT3 group being ionotropic.
  • Hallucinogenic Receptor Excitation:
    • Many hallucinogens can stimulate serotonin-2A receptor sites, despite varying structural similarities to serotonin.
  • Blocking Mechanisms:
    • Medications blocking 5-HT2A receptors can mitigate hallucinogenic impacts; this indicates the significance of such receptors in causing these experiences.
Binding Affinities
  • LSD Binding Potency:
    • The strength of the hallucinogenic effects is directly correlated to a drug's binding affinity for the 5-HT2A receptors.

Acute Effects of LSD

Potency and Dosage Variability

  • Highly Potent:
    • LSD is exceptionally potent, with dosages measured in micrograms.
  • Street Dose Ranges:
    • Typical street doses stretch between 50 - 150 micrograms; effective doses can be as low as 10 micrograms.

Absorption and Duration Characteristics

  • Rapid Absorption Rates:
    • LSD is quickly absorbed orally, with onset within 30-60 minutes, peaking between 2-4 hours and effects may last from 4 to 12 hours.
  • Forms and Presentation:
    • LSD can appear as microdots, windowpanes, or blotters decorated with various images.

Initial Physical Effects

  • Observable Changes Include:
    • Increased heart rate and blood pressure.
    • Pupillary dilation.
    • Minuscule increases in body temperature.
    • Initial feelings may trigger restlessness, euphoria, and release of tension.

Psychedelic Trip Features

  • Characteristic Experiences:
    • Closed-eye visuals presenting vivid colors and complex patterns, with synesthesia noted as cross-sensory perceptions.
    • Users may experience altered perceptions of reality, from significant distortions to intuitively understanding objects’ molecular structures.
    • Features exaggeration in perceptions leading to common objects becoming distorted or unusually enhanced.

Later Phase Effects

  • Mid and Late Sessions:
    • Emotional volatility from joy to anguish may occur.
    • Timelessness noted in altered perceptions of time passage and feelings of unity with the universe, often associating with ego disintegration experiences.

Influence of Set and Setting

  • Expectation Impact:
    • LSD's effects, whether joyous or distressing, are significantly influenced by users’ expectations and environment, impacting overall experience management.

Patterns of LSD Use

Microdosing Trends

  • Microdosing Phenomenon:
    • Involves using sub-perceptual doses of LSD or psilocybin that do not induce hallucinations but may enhance mood, energy, and cognition.

Therapeutic Investigations

  • Potential Applications:
    • Therapeutic capacities are explored for addressing depression, anxiety disorders, PTSD, and drug addiction, although further scrutiny is needed before extensive application.
  • Cautionary Recommendations:
    • Experts discourage unsupervised microdosing sessions, emphasizing significant implications.

LSD and Creativity

  • Perceived Creativity Change:
    • LSD use may engender feelings of enhanced creativity; however, this perception lacks supportive evidence in objective evaluations.
  • Professional Perspectives:
    • Many artists/musicians discern an uptick in quality during LSD experiences, though beliefs diminish post-experience.
  • Controlled Research Findings:
    • Research indicates no substantial lift in creative output when compared to baseline creativity levels.

Initial and Early LSD Research

Evolution of Medical Exploration

  • Early Research Initiatives:
    • Earlier investigations by Osmond and Hoffer targeted LSD for alcoholism treatment perspective; collective analyses emerged later.
  • Meta-Analysis Outcomes:
    • A 2012 meta-analysis encompassing six trials involving 536 participants reported significant efficacy in alcohol misuse reduction post a single LSD dose during treatment processes.
  • Therapeutic Exploration:
    • Clinical trials exhibit possible benefits for anxiety in terminal illness cases and under palliative care, calling for ongoing inquiries into therapeutic potentials.

Psilocybin and Related Entities

Interconnections with Serotonin
  • Source and Tradition:
    • Psilocybin derives from mushrooms found in southern Mexico and Central America, esteemed historically by Aztecs for their visionary properties, evidence appearing in ancient carvings.
  • Documented Effects:
    • Non-hallucinogenic effects were first noted in 1955; Hofmann later cemented psilocybin as the active ingredient.
  • Metabolic Interactions:
    • Psilocybin metabolizes into psilocin within the body, the psychoactive entity influencing neurology.
  • Dosage Parameters:
    • Being less potent than LSD, effective doses lie in the range of:
    • 4-5 mg induces relaxation.
    • 15 mg or more elicits hallucinatory experiences, altering perceptions.
  • Trip Duration:
    • A psilocybin trip lasts approximately 2-5 hours, shorter than LSD experiences, manifesting more visual effects and minor emotional intensities with fewer panic responses witnessed.

High-Dose Implications and Therapeutic Uses

  • Psychotic Experiences:
    • Elevated doses may lead to severe mood shifts and alterations in perception, falling under the category of psychotic experiences.
  • Therapeutic Expansion:
    • Increasing recreational use and therapeutic research indicates potential in conditions like OCD, anxiety, depression, nicotine addiction, and treatment-resistant depression.

Lysergic Acid Amide (LAA)

  • Cultural Context:
    • Morning glory seeds (known as ololuiqui) historically featured in healing rituals and religious practices amongst Aztecs.
  • Identification of Active Components:
    • Hofmann identified LAA as the active constituent, displaying chemical parallels with LSD.
  • Reaction Profile:
    • Effects affine to LSD occur but lack potency (ranging from 1/10th to 1/30th), typically inducing greater auditory than visual hallucinations.
  • Preventative Measures for Abuse:
    • Some commercially available morning glory seeds are coated to incite nausea/vomiting upon consumption, curbing misuse potential.

Dimethyltryptamine (DMT)

  • Extraction Origins:
    • Basically from tree bark/resin found in the West Indies and Central/South America; alternatively inhaled as snuff.
  • Historical Synthesis:
    • Originally synthesized by Richard Manske in 1931; structurally related to LSD and notable serotonin-like hallucinogens.
  • Psychoactive Timelines:
    • Inhaled doses (30 mg) induce physiological alterations within 10 seconds, peaking at 10-15 minutes, competing in effects dissipating within an hour.
  • Side Effects:
    • Users may encounter paranoia, anxiety, and panic during peak experiences.
  • Chemical Relativity:
    • A DMT-like chemical found in Bufo toad toxin mirrors DMT structural aspects.

Harmine's Influence

  • Cultural Use in Ayahuasca:
    • Extracted from Banisteriopsis vine bark common in the Amazon, harmine serves as the primary psychoactive ingredient in ayahuasca, as used in Indigenous remedies.
  • Chemical Impact and Psychological Effects:
    • Harmine's relationship with serotonin yields different psychotropic effects compared to LSD.
  • Experience Overview:
    • Unique effects puzzle LSD-like experiences, often invoking trance states intertwined with dreamlike images featuring animals or supernatural entities; some ayahuasca preparations contain DMT, further enhancing sensations of flight and dissociation.

Hallucinogens Related to Norepinephrine

  • Chemical Composition Analysis:
    • Some hallucinogens bear structural similarities to norepinephrine, potentially influencing arousal and alertness dynamics.
  • Amphetamine-like Effects:
    • Certain hallucinogens contribute stimulant-like effects attributable to norepinephrine similarity.

MDMA (Ecstasy) Overview

Historical Development

  • Initial Synthesis Sequence:
    • MDMA was initially developed in 1914 by Anton Kollisch, patented by Merck.
    • The original intention aimed to curb soldiers' appetites, gaining increased focus in the 1970s for emotional connectivity in psychotherapy.
  • Therapeutic Horizon:
    • Esteemed as an entactogen, it is explored in PTSD treatments, particularly with veterans to navigate trauma-oriented processing without triggering recollections.
  • Recreational Exposure and Associated Risks:
    • Common in nightclub and rave environments; street MDMA often encompasses additives that pose substantial health risks (e.g., hyperthermia, dehydration, cognitive impairments).

Gender Distinctions and Recommendations

  • Behavioral Discrepancies:
    • Women may exhibit heightened behavioral responses to chronic ecstasy use; pregnant women advised against MDMA due to risk exposure.
  • MDMA Purity:
    • Pure MDMA is recognized as relatively safer when managed in controlled scenarios, while most hazards arise from street-acquired contaminants.
  • Potential Therapeutic Opportunities:
    • High purity MDMA produced in legitimate laboratory formats signifies prospective therapeutic values in future applications.

Hallucinogens and Witchcraft Connections

Anticholinergic Drug Dynamics

  • Mechanisms of Interaction:
    • Anticholinergics antagonize parasympathetic acetylcholine functions, which leads to:
    • Diminished mucus and saliva output.
    • Elevated body temperatures, heart rates, and blood pressures.
    • Psychological outcomes comprised of: delirium, confusion, and memory impairments.
  • Key Anticholinergics in Use:
    • Atropine, scopolamine, and hyoscyamine derived from psychoactive plants.
Specific Cases of Anticholinergic Use
  • Atropine Overview:
    • Sourced from Atropa belladonna (deadly nightshade); inhibits muscarinic acetylcholine receptors affecting substantial nervous systems.
    • Historically favored for poisoning incidents; lower dosages facilitate pupil dilation and heart rate increase conducive to arousal states.
  • Mandrake Components:
    • Contains atropine, scopolamine, and hyoscyamine, historically functioning as both sedative-hypnotic at low doses and deleterious at higher dosages.
  • Henbane Uses:
    • Includes scopolamine and hyoscyamine, recognized for anesthetic qualities and analgesic effectiveness at maintained lower dosages, toxic in heightened doses.
  • Datura (Jimsonweed):
    • Known for hypnotic and hallucinogenic abilities, potentially inducing disorientation and poor memory, toxic in higher quantities resulting in hospitalization/death.

Historical Context of Anticholinergic Use

  • Medieval Practices:
    • During historical epochs, concoctions combining deadly nightshade, mandrake, and henbane comprised essential aspects of witches' potions, instigating physiological and psychological effects believed to yield hallucinations and connections to the demonic.

Amanita Muscaria (Fly Agaric) Characteristics

  • Physical Description:
    • Recognizable for bright red cap adorned with white dots; utilized historically as an inebriant.
  • Cultural Significance:
    • Proposed as the ancient soma referenced in Hindu texts as well as potential usage in Greek mystery cults.
  • Active Substances:
    • Muscimol interacts through GABAA receptors opening chloride channels, acting independently of conventional GABA assimilation.
    • Ibotenic acid, converted into muscimol inside the body, operates as a diligent neurotoxin for research-based chemical lesions through amplified glutamatergic neurotransmission.

Behavioral Manifestations and Toxicity Risks

  • Reported Effects:
    • Effects manifest physically through muscular contractions, hallucinations, dizziness, and hostility; historical accounts purported usage by Viking warriors to bolster strength and aggression amid combat.
Understanding the Ibotenic Acid Mechanism
  • Mechanistic Insights:
    • Acts on NMDA receptors to provoke calcium influx, which may incite apoptosis upon overstimulation.

Phencyclidine (PCP) Overview

Pharmacological Background

  • Development Narrative:
    • Originally synthesized as a depressant and surgical anesthetic later withdrawn due to adverse side effects including delirious states and hallucinations, now confined to veterinary medicine.
  • Classification Difficulties:
    • PCP displays an amalgam of stimulant, depressant, and hallucinogenic effects, classifying it as a dissociative anesthetic, inducing perceptual detachment from surrounding populace.

Mechanism of Action

  • Functional Interactions:
    • Serves as a noncompetitive antagonist on NMDA receptors, impeding ion mobility into neurons, impacting cognitive processes and memory formation.
  • Acute Effects:
    • Administered via oral, intravenous, or inhaled modalities, leading to varying symptoms including manic excitement, severe anxiety, mood fluctuations, and pronounced hallucinations that may distort body image.
  • Duration and Aftereffects:
    • PCP's effects can linger from several hours to a fortnight, often succeeded by periods of amnesia and disconnection.

Street Identification Characteristics

  • Common Street Names Include:
    • Variants like Angel Dust, Jet Fuel, and Zombie Dust encapsulate its intense and unpredictable effects.

Ketamine Details

Properties and Usage

  • Dissociative Fundaments:
    • Ketamine serves as a dissociative anesthetic demonstrating both stimulant and depressant elements; utilized primarily in emergency settings.
  • Therapeutic Imbalances:
    • Limited therapeutic efficacy is attributed to side effects encompassing chaotic movements, vivid dream sequences, disorientation, and delusions.
  • Recreational Underpinnings:
    • Refers to street terminology as